John W Mellors Selected Research

John W Mellors Research Topics

Disease

50	Infections 03/2024 - 04/2002
49	Viremia 03/2024 - 04/2002
22	Acquired Immunodeficiency Syndrome (AIDS) 10/2022 - 04/2002
20	COVID-19 12/2023 - 01/2020
16	HIV Infections (HIV Infection) 03/2024 - 07/2003
14	Neoplasms (Cancer) 01/2024 - 04/2015
8	Inflammation (Inflammations) 10/2022 - 04/2017
6	Disease Progression 03/2024 - 04/2002
3	Breakthrough Infections 10/2022 - 12/2015
2	Obesity 12/2023 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2023
2	Critical Illness (Critically Ill) 12/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 10/2020 - 01/2019
2	Lymphoma (Lymphomas) 01/2014 - 08/2013
1	Tuberculosis (Tuberculoses) 05/2024
1	HIV Seropositivity 01/2024
1	Weight Gain 12/2023
1	Body Weight (Weight, Body) 12/2023
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Coinfection 11/2023
1	Severe Acute Respiratory Syndrome 11/2023
1	Adenocarcinoma 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Pregnancy Complications 11/2022

Drug/Important Bio-Agent (IBA)

43	RNA (Ribonucleic Acid)IBA 01/2024 - 04/2002
22	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 11/2010
10	NucleosidesIBA 01/2019 - 04/2002
9	AntibodiesIBA 01/2024 - 06/2020
8	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2002
8	Immunoglobulin G (IgG)IBA 12/2023 - 06/2020
7	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 10/2003
6	Viral RNAIBA 12/2022 - 11/2014
6	VaccinesIBA 01/2022 - 12/2010
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 04/2002
6	Reverse Transcriptase InhibitorsIBA 01/2019 - 04/2007
5	DapivirineIBA 01/2022 - 12/2016
5	Tenofovir (Viread)FDA Link 01/2022 - 07/2010
5	Ritonavir (Norvir)FDA Link 01/2014 - 08/2006
4	Raltegravir Potassium FDA Link 12/2023 - 08/2010
4	Emtricitabine (Emtriva)FDA Link 01/2022 - 01/2016
3	MesothelinIBA 12/2023 - 01/2022
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
3	RacivirIBA 01/2022 - 01/2016
3	Histone Deacetylase InhibitorsIBA 01/2016 - 08/2005
3	efavirenz (Sustiva)FDA Link 04/2011 - 05/2008
3	Lopinavir FDA Link 01/2011 - 11/2006
2	dolutegravirIBA 05/2024 - 12/2023
2	Broadly Neutralizing AntibodiesIBA 03/2024 - 01/2022
2	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2024 - 06/2023
2	AntigensIBA 12/2023 - 11/2023
2	IntegrasesIBA 12/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 12/2023 - 11/2022
2	EpitopesIBA 11/2023 - 01/2021
2	Neutralizing AntibodiesIBA 01/2023 - 01/2021
2	LigandsIBA 01/2022 - 01/2019
2	FumaratesIBA 01/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 08/2021 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2015
2	Monoclonal AntibodiesIBA 01/2021 - 01/2019
2	Nucleic AcidsIBA 01/2021 - 08/2013
2	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 06/2013
2	Nevirapine (Viramune)FDA Link 10/2019 - 01/2008
2	Viral DNAIBA 11/2015 - 01/2013
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2014 - 08/2006
2	Indinavir (Crixivan)FDA Link 11/2010 - 11/2003
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2024
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	Cell-Free Nucleic AcidsIBA 11/2023
1	mRNA VaccinesIBA 11/2023
1	Investigational DrugsIBA 11/2023
1	Carcinoembryonic AntigenIBA 01/2023
1	Cell Adhesion MoleculesIBA 01/2023
1	Muromonab-CD3 (Muromonab CD3)FDA Link 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2023
1	Contraceptive Agents (Contraceptives)IBA 10/2022
1	TabletsIBA 01/2022
1	cabotegravirIBA 01/2022
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2022
1	islatravirIBA 01/2022
1	env Gene ProductsIBA 01/2022
1	Natural Killer Cell ReceptorsIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2021

Therapy/Procedure

68	Therapeutics 03/2024 - 04/2002
31	Art Therapy 03/2024 - 04/2002
13	Highly Active Antiretroviral Therapy (HAART) 01/2023 - 12/2004
4	Immunotherapy 01/2023 - 01/2019
4	Injections 10/2022 - 03/2016
4	Female Contraceptive Devices (Vaginal Ring) 01/2021 - 12/2016
2	Artificial Respiration (Mechanical Ventilation) 12/2023 - 11/2022
2	Stem Cell Transplantation 01/2014 - 08/2013
1	Noninvasive Ventilation 12/2023
1	Extracorporeal Membrane Oxygenation 12/2023
1	Prenatal Care (Care, Prenatal) 10/2022
1	Castration 01/2022